Receptor Editing Occurs Frequently During Normal B Cell Development
Overview
General Medicine
Authors
Affiliations
Allelic exclusion is established in development through a feedback mechanism in which the assembled immunoglobulin (Ig) suppresses further V(D)J rearrangement. But Ig expression sometimes fails to prevent further rearrangement. In autoantibody transgenic mice, reactivity of immature B cells with autoantigen can induce receptor editing, in which allelic exclusion is transiently prevented or reversed through nested light chain gene rearrangement, often resulting in altered B cell receptor specificity. To determine the extent of receptor editing in a normal, non-Ig transgenic immune system, we took advantage of the fact that lambda light chain genes usually rearrange after kappa genes. This allowed us to analyze kappa loci in IgMlambda+ cells to determine how frequently in-frame kappa genes fail to suppress lambda gene rearrangements. To do this, we analyzed recombined VkappaJkappa genes inactivated by subsequent recombining sequence (RS) rearrangement. RS rearrangements delete portions of the kappa locus by a V(D)J recombinase-dependent mechanism, suggesting that they play a role in receptor editing. We show that RS recombination is frequently induced by, and inactivates, functionally rearranged kappa loci, as nearly half (47%) of the RS-inactivated VkappaJkappa joins were in-frame. These findings suggest that receptor editing occurs at a surprisingly high frequency in normal B cells.
Kidins220 regulates the development of B cells bearing the λ light chain.
Schaffer A, Fiala G, Hils M, Natali E, Babrak L, Herr L Elife. 2024; 13.
PMID: 38271217 PMC: 10810608. DOI: 10.7554/eLife.83943.
Okoreeh M, Kennedy D, Olumide Emmanuel A, Veselits M, Moshin A, Ladd R Sci Immunol. 2022; 7(74):eabm1664.
PMID: 35930652 PMC: 9636592. DOI: 10.1126/sciimmunol.abm1664.
A case of solitary plasmacytoma of bone showing co-expression of both immunoglobulin light chains.
Matsuoka R, Sakamoto N, Kato T, Chiba S, Noguchi M Eur J Med Res. 2021; 26(1):148.
PMID: 34930458 PMC: 8686560. DOI: 10.1186/s40001-021-00621-8.
Collins A, Watson C Front Immunol. 2018; 9:2249.
PMID: 30349529 PMC: 6186787. DOI: 10.3389/fimmu.2018.02249.
Ottens K, Hinman R, Barrios E, Skaug B, Davis L, Li Q J Immunol. 2018; 201(3):940-949.
PMID: 29950509 PMC: 6057821. DOI: 10.4049/jimmunol.1701070.